ReviewTraumatic brain injury: A risk factor for Alzheimer's disease
Highlights
► Traumatic brain injury (TBI) is an important epigenetic risk factor for the development of Alzheimer's disease. ► Aβ plaques which are pathological features of Alzheimer's disease are seen in 30% patients who die of TBI. ► Although many patients survive the initial insult, TBI initiates a chronic disease process. ► As TBI affects many areas of the brain, a multiplicity of neurobehavioral symptoms is common after TBI.
Introduction
National Head Injury Foundation (1988) has defined traumatic brain injury (TBI) as “an insult to the brain caused by an external force that may produce diminished or altered states of consciousness, which results in impaired cognitive abilities or physical functioning”. About 1.4 million people suffer from TBI every year in the United States alone (Zohar et al., 2011). The yearly cost of acute care and rehabilitation for new cases in the United States is between $9 and $10 billion (NIH Consensus Development Panel, 1999). TBI affects all age groups with particular prevalence among children and young adults (Fins, 2003, Kövesdi et al., 2010). It is the leading cause of acquired disability in children (Cronin, 2001). Survivors of TBI suffer from a wide variety of pathologies such as neurological deficits, short and long term brain damage, cognitive, behavioral and emotional impairments, all of which depend on the severity of injury. Neurological deficits in cognition are due to atrophy of hippocampus and damage of white matter tract as evident from functional imaging studies (Atkins et al., 2009).
TBI can be classified as (i) focal damage, which occurs in localized area and causes damage to the underlying brain tissues and vessels, and (ii) diffuse damage, which is not restricted but widespread throughout the brain. Diffuse type mainly involves axonal injury also called diffuse axonal injury (DAI), brain swelling and hypoxia (Hellewell et al., 2010, Laurer et al., 2000). Axonal injury is an almost universal sequel of TBI (Li et al., 2006, Smith, 2000) and a powerful predictor of morbidity and mortality (Czeiter et al., 2008). In axons, it causes an accumulation of proteins, including amyloid precursor protein (APP), which is carried by fast anterograde axonal transport and serves as a sensitive marker of axonal damage. This may result in axonal disconnection leading to loss of axonal function and structure (Chen et al., 2004). TBI is one of the most consistent candidates for initiating the molecular cascades that result in Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (Gavett et al., 2010).
Section snippets
TBI initiates a disease process
Although many patients survive the initial insult, TBI initiates a chronic disease process that may ultimately contribute to their deaths months to years later (Masel and DeWitt, 2010). Cell death after TBI is a major cause of neurological deficits and mortality (Stoica and Faden, 2010, Yu et al., 2008). TBI is a disease process with an initial injury that induces biochemical and cellular changes which in turn contribute to continuing neuronal damage and death over time. This continuing damage
TBI and Alzheimer's disease
TBI is a strong epigenetic risk factor for AD (Fleminger et al., 2003, Magnoni and Brody, 2010, Plassman et al., 2000) which is a neurodegenerative disorder characterized by the presence of extracellular senile plaques and intracellular neurofibrillary tangles (NFTs) (Slemmer et al., 2011). Senile plaques are formed of aggregates of amyloid beta (Aβ) peptides, whereas NFTs are composed of bundles of pathological fibrils called paired helical filaments (PHFs), which are made up of aberrantly
Neurobehavioral sequelae of TBI
Because TBI affects many areas of the brain, a multiplicity of neurobehavioral symptoms is common after TBI. It includes cognitive impairments, personality changes, aggression, impulsivity, apathy, anxiety, depression, mania and psychosis (Riggio, 2010). Patients often complain of headache or dizziness after head injury (Shawn et al., 2007). Comprehensive mental status testing frequently reveals symptoms of depression or memory dysfunction and requires psychiatric consultation. The two
Conclusions
TBI initiates many different signaling cascades throughout the brain that impact both pathophysiological and neuroprotective processes. Cellular mechanisms that can modulate these processes may play an important role in determining the nature and extent of the damage suffered after TBI and therefore influence overall outcome after injury. Many studies support the hypothesis that the survivors of TBI have a major risk of developing AD. The link between TBI and later development of
Acknowledgements
The authors thank Prof. Rita Christopher, NIMHANS, Bangalore, for critically reading the manuscript and giving useful comments for its improvement. Research work in authors’ laboratory is funded by grants from the Council of Scientific and Industrial Research (CSIR), Department of Science and Technology (DST), Department of Biotechnology (DBT) and Indian Council of Medical research (ICMR), Government of India.
References (95)
- et al.
Caspase inhibition therapy abolishes brain trauma induced increases in Aβ peptide: implications for clinical outcome
Exp. Neurol.
(2006) - et al.
Deficit in ERK and CREB activation in the hippocampus after traumatic brain injury
Neurosci. Lett.
(2009) - et al.
Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem
Neurotherapeutics
(2010) - et al.
Long term accumulation of amyloid-β, β-secretase, presenilin1, and caspase 3 in damaged axons following brain trauma
Am. J. Pathol.
(2004) - et al.
The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains
Brain Res.
(2011) - et al.
Apolipoprotein E genotype and oxidative stress response to traumatic brain injury
Neuroscience
(2010) - et al.
Beta amyloid precursor protein (β-APP) as a marker for axonal injury after head injury
Neurosci. Lett.
(1993) - et al.
Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease
Biochim. Biophys. Acta
(2011) - et al.
Preliminary study on the effect of trauma-induced secondary cellular hypoxia in brain injury
Neurosci. Lett.
(2010) - et al.
Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury
Exp. Neurol.
(2004)
Transient cognitive deficits are associated with the reversible accumulation of amyloid precursor protein after traumatic brain injury
Neurosci. Lett.
T proteins in serum predict outcome after severe traumatic brain injury
J. Surg. Res.
Personalized medicine in traumatic brain injury
Psychiatr. Clin. North Am.
Pathobiology of traumatically induced axonal injury in animals and man
Ann. Emerg. Med.
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors
Brain. Res. Rev.
Traumatic brain injury and its neurobehavioral sequelae
Psychiatr. Clin. North Am.
Calpain as therapeutic target in traumatic brain injury
Neurotherapeutics
Age-dependent response of CCAAT/enhancer binding proteins following traumatic injury in mice
Neurochem. Int.
Traumatic brain injury reduces soluble extracellular amyloid-β in mice: a methodologically novel combined microdialysis-controlled cortical impact study
Neurobiol. Dis.
Cell death mechanisms and modulation in traumatic brain injury
Neurotherapeutics
Voluntary exercise may engage proteosome function to benefit the brain after trauma
Brain Res.
Depletion of GGA3 stabilizes BACE and enhances β-secretase activity
Neuron
Estradiol regulates APP mRNA alternative splicing in the mice brain cortex
Neurosci. Lett.
Multiple proteins implicated in neurodegenerative disease accumulate in axons after brain trauma in humans
Exp. Neurol.
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following close head injury: evidence of pharmacogenomic interaction
Neuroscience
Increased β-secretase activity and expression in rats following transient cerebral ischemia
Brain Res.
Ubiquitin and ubiquitin-conjugated protein expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI)
Brain Res.
Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and-amyloid generation
J. Biol. Chem.
Pathological role of hypoxia in Alzheimer's disease
Exp. Neurol.
PKC activator therapeutic for mild traumatic brain injury in mice
Neurobiol. Dis.
Impaired expression of neuroprotective molecules in the HIF-1 α pathway following traumatic brain injury in aged mice
J. Neurotrauma
Apolipoprotein E and brain injury: implications of children
Dev. Med. Child Neurol.
Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis
Diabetes
Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury
J. Neurochem.
Traumatic brain injury in children: issues in community function
Am. J. Occup. Ther.
Traumatic axonal injury in the spinal cord evoked by traumatic brain injury
J. Neurotrauma
Proteosomal degradation of tau protein
J. Neurochem.
Constructing an ethical stereotaxy for severe brain injury: balancing risks, benefits and access
Nat. Rev. Neurosci.
Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication
J. Neurol. Neurosurg. Psychiatry
In situ detection of inflammatory mediators in post mortem human tissue after traumatic injury
J. Neurotrauma
Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model
J. Neurosci.
Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury
J. Neurotrauma
Mild traumatic brain injury: a risk factor for neurodegeneration
Alzheimer's Res. Ther.
Protein aggregation and proteosome dysfunction after brain ischemia
Stroke
Age related mitochondrial changes after traumatic brain injury
J. Neurotrauma
Head injury doubles the risk of Alzheimer's disease
Br. Med. J.
Amyloid precursor protein is trafficked and secreted via synapric vesicles
PLoS One
Cited by (241)
Synaptic and mitochondrial alterations in traumatic brain injury (TBI): neuroprotective effects of phytochemicals and herbal products
2023, Ayurvedic Herbal Preparations in Neurological DisordersPhysical memory of astrocytes
2022, Brain ResearchCitation Excerpt :Traumatic brain injury (TBI) is a significant public health concern and one of the leading risk factors for development of chronic neurodegenerative disorders including Alzheimer's disease (AD) (Cruz-Haces et al., 2017; Sivanandam and Thakur, 2012).